London, September 12, 2016 – QualiTest, a global leader in pure-play software testing and business assurance services, today announced that it has signed a definitive agreement to be acquired by Marlin Equity Partners (“Marlin”), a global investment firm with more than $3 billion of capital under management. QualiTest, founded in 1998 by Eli Margolin and Ayal Zylberman, was previously controlled by the two co-founders, Kedma Capital and Goldrock Capital, Israel-based private equity firms. Marlin is acquiring the shares held by Kedma Capital, Goldrock Capital and Eli Margolin, while Ayal Zylberman, who currently serves as the CEO, is expected to continue to lead the company following the acquisition. QualiTest provides end-to-end testing and quality assurance services that help companies mitigate business risks associated with the software they release. In recent years the company has expanded its operations successfully into the US, UK and Indian markets through a combination of acquisitions and organic growth. “QualiTest’s organic growth is a result of combining customer-centric business models, critical thinking and a deep focus on our customers’ challenges and goals,” said Ayal Zylberman, QualiTest’s co-founder and CEO. “We are excited to have found a strong partner in Marlin to help support us in accelerating our organic growth, executing our ambitious acquisition strategy and delivering outstanding value to our customers.” About QualiTest QualiTest is the world second largest pure-play outsourced software testing and quality assurance specialist with offices in the United States, the United Kingdom, Israel, and India. QualiTest focuses on large global enterprises in the technology, telecom, healthcare, finance, defense, media, utilities and retail industries and offers a wide range of testing solutions to meet customer’s business requirements, from engagement models to tailored testing by industry. QualiTest designs and delivers contextualized solutions that leverage deep industry-specific understanding with technology-specific competencies and unique testing-focused IP, products and methodologies.